In an effort to enhance its profitability, MRI vendor Fonar has begun a program of selling its MRI scanners to its wholly owned physician and medical imaging management subsidiary, Health Management Corporation of America (HMCA). HMCA operates 25 medical
In an effort to enhance its profitability, MRI vendor Fonar has begun a program of selling its MRI scanners to its wholly owned physician and medical imaging management subsidiary, Health Management Corporation of America (HMCA). HMCA operates 25 medical imaging centers and 12 primary-care and multispecialty offices in New York, Florida, Pennsylvania, and Georgia. Melville, NY-based Fonar will provide financing for HMCA under a lease arrangement and expects the strategy of upgrading select HMCA-managed facilities to improve the subsidiarys operating profits and productivity.
Fonar announced last week that its first placement will be one of its open systems, 0.6-tesla magnet Quad 12000, to HMCAs Garden City, NY, medical imaging center. HMCAs executive director of diagnostic operations, Xavier Rodrigo, attributed the decision to install the unit at this particular center to the facilitys already increased revenues and scan volume. The system will be installed next quarter.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.